Medical robotics is a fast-growing field in the medical device industry. The surgical robotics segment is leading the market. The surgical robotics market can be segmented into capital equipment and consumable accessories. The robotic surgical system accessories occupy the majority of the market, driven by the demands of high-volume procedures.
Based on procedure types, the surgical robotics market can be broadly divided into three primary sub-segments: general surgery robotics, orthopaedic robotics, and neurosurgery robotics.
Leading medical device companies in robotics
Medical robotics is an emerging field in healthcare, and each of the segments have unique challenges and expectations for success as they continue their development over the next decade. While the markets for exoskeletons, care robots, and hospital robots are still in the early stage of market development, the market for surgical robotic systems, which are used to perform minimally invasive procedures that might otherwise be difficult with traditional open or laparoscopic techniques, is surging rapidly in the past few years.
Discover the leading robotics companies in the medical device industry
Using its experience in the sector, Medical Device Network has listed some of the leading companies providing products and services related to robotics.
The information provided in the download document is drafted for medical device executives and technology leaders involved in medical device robotics solutions.
The download contains detailed information on suppliers and their product offerings, alongside contact details to aid purchase or hiring decisions.
Among the leading robotics suppliers are Intuitive Surgical, Stryker, Medtronic, Johnson & Johnson, Ekso Bionics, CMR Surgical, Globus Medical, MicroPort Scientific, ReWalk Robotics, and Smith & Nephew.
Future of robotics in the medical device industry
According to GlobalData forecasts, the total surgical robotics market was worth $4.6bn in 2020 globally. By 2030, it will have grown at a strong compound annual growth rate (CAGR) of 8.5% to $10.3bn, bolstered by the coming marriage of artificial intelligence (AI) and robotics within medical devices.